Final answer:
The percentage of CFTR mutation carriers in an Asian population that would be detectable with a 23 mutation panel is not provided, and this rate is highly dependent on the frequency of the targeted mutations within the specific population. Mutation panels are generally more effective in populations where their target mutations are more prevalent.
Step-by-step explanation:
In a population of Asian descent, the percentage of cystic fibrosis transmembrane conductance regulator (CFTR) mutation carriers that would be detectable using the current basic mutation panel for CFTR (23 mutation panel) is not specified in the provided reference information. The panel is designed to target common CFTR mutations; however, different populations have different frequencies of these mutations. For instance, the most common CF mutation, ΔF508, is present in about 70% of all CF alleles in Northern European populations, but it is significantly less common in Asian populations.
Therefore, to determine the effectiveness of a 23 mutation panel in a specific population, one would need data on the frequency of the included mutations within that population. This information is vital because the basic mutation panel was originally designed with a focus on mutations common in populations of Northern European descent, where approximately 90% of CF mutations can be detected with a 23 mutation panel. In contrast, the detection rate for Asian populations may be lower due to the different mutation spectrums.